NIH-funded research NIH-funded research

Mapping the effects of amyloid deposits in the aging brain

Official title: Project 3: 3-D Molecular Atlas of cerebral amyloid angiopathy in the aging brain with and without co-pathology

Funded at Columbia University Health Sciences · NIH-10935941 · Data updated 2026-11-12

This study is looking at how cerebral amyloid angiopathy (CAA), a condition that often comes with aging, affects brain cells and their environment, especially in relation to Alzheimer's disease, to help us better understand these conditions and find new ways to treat them.

More Aging research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionColumbia University Health Sciences
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 30, 2023
Project endAugust 31, 2028
Funding year2024
Award (this year)$504,727
NIH project number5U19AG074862-02
Project IDNIH-10935941 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are older adults who have been diagnosed with Alzheimer's disease or exhibit symptoms of cognitive decline.

Less likely to help

Patients without any signs of cognitive impairment or those who are not elderly may not benefit from this research.

What this research studies

This research investigates how cerebral amyloid angiopathy (CAA), a condition associated with aging, affects the brain's cellular environment in specific regions. By examining post-mortem human brain tissue, the study aims to create a detailed 3-D molecular atlas that highlights the interactions between CAA and Alzheimer's disease pathology. The researchers will analyze how CAA influences the composition and function of brain cells, potentially leading to cognitive decline. This work seeks to enhance our understanding of the relationship between CAA and Alzheimer's disease, which could inform future treatments.

Why it matters

Potential benefit: If successful, this research could lead to improved strategies for diagnosing and treating cognitive decline associated with Alzheimer's disease and CAA.

How similar studies have gone: Previous research has shown promising results in understanding the effects of amyloid deposits on brain function, but this specific approach of creating a 3-D molecular atlas is relatively novel.

Where this research is happening

  • Columbia University Health Sciences
    New York, United States
    Active

Researchers

  • Principal investigator: Schneider, Julie a. — Columbia University Health Sciences
  • Study coordinator: Schneider, Julie a.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.